Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV. (Q43941501)

28 November 2017

Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV. (English)

1 reference

28 November 2017

1 reference

Lactobacillus rhamnosus

object named as

Lactobacillus rhamnosus

1 reference

2

John Changalucha

1 reference

28 November 2017

6

Gregor Reid

1 reference

28 November 2017

Ruben Hummelen

1

1 reference

28 November 2017

Nicodemus L Butamanya

series ordinal

3

1 reference

28 November 2017

Adrian Cook

series ordinal

4

1 reference

28 November 2017

J Dik F Habbema

series ordinal

5

1 reference

28 November 2017

language of work or name

1 reference

1 December 2010

1 reference

International Journal of Gynecology and Obstetrics

28 November 2017

1 reference

28 November 2017

111

1 reference

28 November 2017

245-248

1 reference

28 November 2017

3

1 reference

The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women.

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.07.008

Microbicides development program, Tanzania-baseline characteristics of an occupational cohort and reattendance at 3 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.07.008

HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.07.008

Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.07.008

Disentangling contributions of reproductive tract infections to HIV acquisition in African Women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.07.008

Intermittent intravaginal antibiotic treatment of bacterial vaginosis in HIV-uninfected and -infected women: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.07.008

Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.07.008

Nucleic acid-based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.07.008

Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.07.008

Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.07.008

The efficacy and safety of probiotic Lactobacillus rhamnosus GG on prolonged, noninfectious diarrhea in HIV Patients on antiretroviral therapy: a randomized, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.07.008

Bacterial vaginosis: review of treatment options and potential clinical indications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.07.008

Utilization of the intestinal tract as a delivery system for urogenital probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.IJGO.2010.07.008

10.1016/J.IJGO.2010.07.008

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference